The TCF3/PBX1 fusion oncogene (two transactivation domains of TCF3 fused to the C-terminal portion of PBX1) is under the control of lymphoid-specific promoter/enhancer elements in the pLIT3 expression vector, that include sequences from the proximal promoter of the Lck gene, immunoglobulin enhancer elements, and a TCR Vbeta promoter. The human growth hormone gene with a frameshift mutation in the coding region was inserted 3' of the transgene cDNA to provide introns that enhance the expression. Western blot analysis confirmed expression of the fusion protein in the bone marrow, spleen, and thymus. (J:95693)

Basic Information

Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Gene Expression
Related Disease
Reference
(C57BL/6J x C3H)F2
--
Insertion
--
2
--
2

Phenotypes

Legend:
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes:
Show/Hide columns
Phenotypes

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Comparison
Al agent
Tutorials
Back to top